FNY Managed Accounts’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-43	Closed	-$3K	–	710
2017 Q4	$3K	Buy	+43	New	+$3K	﹤0.01%	384
2017 Q2	–	Sell	-82	Closed	-$3K	–	453
2017 Q1	$3K	Buy	+82	New	+$3K	0.01%	681